ArticleNew cure strategies for Hepatitis B are in development. Emerging data suggests a key role for biomarkers to identify subsets of people living with Hepatitis B who are most likely to respond to treatment. In this webinar, we discussed recent advances in Hepatitis B biomarker development, and how these tools can be used to personalise the management of people living with Hepatitis B.
Is Hepatitis B entering the era of personalised medicine?
LabInsights の最新ニュースと更新を受け取ることができます
同じトピックの記事
LabInsights の最新ニュースと更新を受け取ることができます
次のおすすめ記事
- Healthcare Transformation, Management, Operations, Population Health Management
- Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
- Clinician Engagement, Coagulation, Disease Area, Management
